← Back to Clinical Trials
Recruiting NCT06215040

The Treatment Effect for Asymptomatic Common Bile Duct Stone

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Choledocholithiasis
Sponsor Kyungpook National University Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 120
Sex ALL
Min Age 18 Years
Max Age 85 Years
Start Date 2024-01-02
Completion 2027-12-31
Interventions
Endoscopic retrograde cholangiopancratography

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study is prospective, multicenter study for identify the characteristics of asymptomatic common bile duct stones and effectiveness of treatment.

Eligibility Criteria

Inclusion Criteria: * diagnosed as common bile duct stone by image modality examination * agreement for this study enrollment Exclusion Criteria: * no definite common bile duct stone by image modality examination * symptomatic patients who complain with fever/abdominal pain that compatible with common bile duct stone related symptom * previously diagnosed as pancreatobiliary malignancy * previously treated by endoscopic or percutaneous treatment for bile duct stones * severe cardio or pulmonary disease * pregnancy or possibility of pregnancy * who do not agree with study enrollment

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}